Lifecore Biomedical (Lifecore Biomedical) Equity-to-Asset

Lifecore Biomedical Annual Data
	Trend	May14	May15	May16	May17	May18	May19	May20	May21	May22	May23
Equity-to-Asset		Get a 7-Day Free Trial					0.52	0.43	0.40	0.32	-0.02

Lifecore Biomedical Quarterly Data
	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23
Equity-to-Asset	Get a 7-Day Free Trial															0.32	0.34	0.27	0.15	-0.02

For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Lifecore Biomedical's Equity-to-Asset falls into.

Lifecore Biomedical Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Lifecore Biomedical's Equity to Asset Ratio for the fiscal year that ended in May. 2023 is calculated as

Lifecore Biomedical's Equity to Asset Ratio for the quarter that ended in May. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifecore Biomedical  (NAS:LFCR) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Lifecore Biomedical Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Lifecore Biomedical's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Lifecore Biomedical (Lifecore Biomedical) Business Description